Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02418923 · ClinicalTrials.gov registry record
HemoSonics-UVA Spinal Surgery
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 51
- Enrollment target
NCT02418923: Completed study, sponsored by University of Virginia.
NCT02418923 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02418923 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in neurosurgery patients.
Primary Outcome
Demonstrate assay inter-instrument variability below 15%
Interventions
- OTHER Procedure: Blood specimen collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2015-04 |
| Est. Completion | 2015-08 |
What the finished NCT02418923 record still lists
NCT02418923 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Procedure: Blood specimen collection is the first listed.
NCT02418923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02418923 about?
NCT02418923 is a clinical study titled "HemoSonics-UVA Spinal Surgery". This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in neurosurgery patients.
What is the current status of trial NCT02418923?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2015-04. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02418923?
The interventions under investigation include: Procedure: Blood specimen collection (OTHER).
Who is sponsoring clinical trial NCT02418923?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia